Xreal Air Lens Ships First Consumer AR Contact Lens, Promises 'Invisible Computing'

Tokyo, November 10, 2027 — Xreal has begun shipping the Air Lens, what it calls the world's first consumer-grade augmented reality contact lens, to 12,000 pre-order customers in Japan, South Korea, and the United States. The device, priced at $1,899 per pair, overlays a monochromatic green micro-OLED display directly onto the wearer's field of vision at an apparent brightness of 3,000 nits.

Unlike previous AR眼镜 (smart glasses) products that sit in front of the eyes, the Air Lens sits directly on the cornea as a gas-permeable contact lens, making it functionally invisible to observers. The lens contains a custom 8nm SoC developed in partnership with Samsung Foundry, 2MB of embedded memory, a pressure sensor, and a micro-mirror array that reflects the OLED display into the wearer's line of sight.

Power is delivered wirelessly via a paired smartwatch-style charging coil embedded in a glasses frame that the user wears simultaneously—essentially a thin pair of non-prescription acetate frames that serve purely as a power relay. The charging case fully recharges the frames in 90 minutes; the lenses themselves carry a 6-hour active-use battery.

The Air Lens requires no smartphone tether and runs Xreal's NebulaOS natively, offering navigation overlays, real-time translation subtitles, and notification peeking. Prescription versions are available in myopia up to -12 diopters and hyperopia up to +6 diopters. The company has partnered with 340 ophthalmologists globally for fitting and follow-up care.

Xreal CEO Chi Xu described the device as the culmination of a seven-year development effort. "This is the end of wearing computers on your face," he said at the launch event in Tokyo. "Computing becomes invisible—in your eye, not in front of it."

Medical professionals have flagged concerns. The American Academy of Ophthalmology issued a statement noting that while the lens is FDA-cleared for daily wear up to 8 hours, the long-term effects of extended micro-OLED exposure on corneal tissue remain under study. Xreal says it has completed a two-year wearability trial with 800 participants with no serious adverse events.